It also addresses the FDA’s communications With all the applicant, the retention of documents that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer ownership of an SE report to a fresh applicant and Digital submission on the SE report and amendments.(